Your browser doesn't support javascript.
loading
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Noordman, Bo Jan; Spaander, Manon C W; Valkema, Roelf; Wijnhoven, Bas P L; van Berge Henegouwen, Mark I; Shapiro, Joël; Biermann, Katharina; van der Gaast, Ate; van Hillegersberg, Richard; Hulshof, Maarten C C M; Krishnadath, Kausilia K; Lagarde, Sjoerd M; Nieuwenhuijzen, Grard A P; Oostenbrug, Liekele E; Siersema, Peter D; Schoon, Erik J; Sosef, Meindert N; Steyerberg, Ewout W; van Lanschot, J Jan B.
Afiliación
  • Noordman BJ; Department of Surgery, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands. Electronic address: b.noordman@erasmusmc.nl.
  • Spaander MCW; Department of Gastroenterology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
  • Valkema R; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
  • Wijnhoven BPL; Department of Surgery, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
  • van Berge Henegouwen MI; Department of Surgery, Academic Medical Centre, Amsterdam, Netherlands.
  • Shapiro J; Department of Surgery, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
  • Biermann K; Department of Pathology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
  • van der Gaast A; Department of Medical Oncology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
  • van Hillegersberg R; Department of Surgery, University Medical Centre Utrecht, Utrecht, Netherlands.
  • Hulshof MCCM; Department of Radiation Oncology, Academic Medical Centre, Amsterdam, Netherlands.
  • Krishnadath KK; Department of Gastroenterology, Academic Medical Centre, Amsterdam, Netherlands.
  • Lagarde SM; Department of Surgery, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
  • Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands.
  • Oostenbrug LE; Department of Gastroenterology, Zuyderland Medical Centre, Heerlen, Netherlands.
  • Siersema PD; Department of Gastroenterology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands; Department of Gastroenterology, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Schoon EJ; Department of Gastroenterology, Catharina Hospital, Eindhoven, Netherlands.
  • Sosef MN; Department of Surgery, Zuyderland Medical Centre, Heerlen, Netherlands.
  • Steyerberg EW; Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands; Department of Medical Statistics and Bioinformatics, Leiden University Medical Centre, Leiden, Netherlands.
  • van Lanschot JJB; Department of Surgery, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.
Lancet Oncol ; 19(7): 965-974, 2018 07.
Article en En | MEDLINE | ID: mdl-29861116
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Neoplasia Residual / Quimioradioterapia Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Neoplasia Residual / Quimioradioterapia Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article